ATE344264T1 - Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger - Google Patents

Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger

Info

Publication number
ATE344264T1
ATE344264T1 AT04005777T AT04005777T ATE344264T1 AT E344264 T1 ATE344264 T1 AT E344264T1 AT 04005777 T AT04005777 T AT 04005777T AT 04005777 T AT04005777 T AT 04005777T AT E344264 T1 ATE344264 T1 AT E344264T1
Authority
AT
Austria
Prior art keywords
compound
porphyrin
oxygen carrier
albumin
artificial oxygen
Prior art date
Application number
AT04005777T
Other languages
English (en)
Inventor
Elshun Tsuchida
Teruyuki Komatsu
Akito Nakagawa
Naomi Ohmichi
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Application granted granted Critical
Publication of ATE344264T1 publication Critical patent/ATE344264T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
AT04005777T 2003-03-14 2004-03-11 Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger ATE344264T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003069760A JP3945428B2 (ja) 2003-03-14 2003-03-14 ポルフィリン化合物、そのアルブミン包接化合物および人工酸素運搬体

Publications (1)

Publication Number Publication Date
ATE344264T1 true ATE344264T1 (de) 2006-11-15

Family

ID=32866679

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04005777T ATE344264T1 (de) 2003-03-14 2004-03-11 Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger

Country Status (5)

Country Link
US (3) US20040180837A1 (de)
EP (1) EP1466915B1 (de)
JP (1) JP3945428B2 (de)
AT (1) ATE344264T1 (de)
DE (1) DE602004002975T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232818A (ja) * 2005-01-25 2006-09-07 Nipro Corp ポルフィリン金属錯体とアルブミンとの包接化合物
US20060166861A1 (en) * 2005-01-25 2006-07-27 Yoshinori Kida Inclusion compound of porphyrin metal complex and albumin
EP1704870A1 (de) * 2005-03-25 2006-09-27 Nipro Corporation Verwendung von Eisenverbindungen als Radiosensitizer
AU2017267955B2 (en) 2016-05-19 2020-08-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
JP2019099488A (ja) * 2017-11-30 2019-06-24 小林製薬株式会社 ペプチド及びその利用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59162924A (ja) 1983-03-09 1984-09-13 Hidetoshi Tsuchida 酸素吸脱着剤
JPS59164791A (ja) 1983-03-09 1984-09-17 Hidetoshi Tsuchida 2位に置換基を有する5,10,15,20―テトラ〔α,α,α,α―o―(ピバラミド)フェニル〕ポルフィリン化合物
JP3312953B2 (ja) 1993-03-22 2002-08-12 財団法人生産開発科学研究所 2位置側鎖を有するテトラフェニルポルフィリン金属錯体及びその製造法
JP3428225B2 (ja) * 1995-04-28 2003-07-22 三菱ウェルファーマ株式会社 ポルフィリン金属錯体−アルブミン包接化合物及び酸素運搬体
JP3432190B2 (ja) 1999-11-09 2003-08-04 英俊 土田 ポルフィリン金属錯体−アルブミン多量体包接化合物、及びそれを有効成分とする酸素輸液剤

Also Published As

Publication number Publication date
JP2004277329A (ja) 2004-10-07
US7595394B2 (en) 2009-09-29
US20040180837A1 (en) 2004-09-16
EP1466915B1 (de) 2006-11-02
EP1466915A1 (de) 2004-10-13
JP3945428B2 (ja) 2007-07-18
DE602004002975D1 (de) 2006-12-14
US20090182125A1 (en) 2009-07-16
US7754879B2 (en) 2010-07-13
US20060003923A1 (en) 2006-01-05
DE602004002975T2 (de) 2007-04-12

Similar Documents

Publication Publication Date Title
HUS2000011I1 (hu) A 2,4-pirimidin-diamin vegyületek elõgyógyszerei és alkalmazásuk
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
BRPI0317696B8 (pt) composição para branqueamento
BR0313342A (pt) Método de preparação de compostos
EP1371640A4 (de) Neues a-liponsäurederivat und dessen verwendung
DE60230890D1 (de) Indolizine als kinaseproteinhemmer
IN2012DN02609A (de)
ATE451349T1 (de) Neue verbindungen als entzündungshemmende, immunmodulierende und antiproliferative mittel
WO2002100860A3 (fr) Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
DE60132171D1 (de) Tocopherole, tocotrienole, andere chrome und seitenketten-derivate und ihre verwendung
BRPI0512310A (pt) compostos quìmicos
PT1975164E (pt) Compostos de octa-hidrobenzimidazolona utilizados como analgésicos
EP1304121A4 (de) Inhibitoren der koerpergewichtszunahme
MXPA04009476A (es) Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7.
WO2007025089A3 (en) Triazole compounds and methods of making and using the same
ATE344264T1 (de) Porphyrin-verbindung, deren albumin- einschlussverbindung und künstlicher sauerstoffträger
WO2005009345A3 (en) 2-desmethyl ansamycin compounds
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
AU2002342498A1 (en) Organic compounds
DE602005009707D1 (de) Metallkomplexierte phospholderivate und pharmazeutische verwendungen dafür
DE69937771D1 (de) 1-Aryl-4-cycloalk(en)ylpyrazole als antiparasitäre Mittel
DE602004009313D1 (de) Organosiliziumverbindungen und deren verwendung
EP1186616A4 (de) Antifucoidan antikörper
DE60311000D1 (de) Indolderivate und deren verwendung als 5-ht liganden
ATE448198T1 (de) Neue alpha-ketoamidderivate und deren verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties